Efficacy and potential microRNA mechanism for computed tomography-guided percutaneous radiofrequency ablation of primary lung cancer and lung metastasis from liver cancer

Cellular Physiology and Biochemistry

Volumn 33, Issue 5, 2014, Pages 1261-1271

  Hu, Xun ^a,b   Zhang, Fan ^a   Liu, Xiao Rong ^a   Wu, Yun Tao ^a   Ni, Yi Ming ^b  

^a The Second Hospital of Jiaxing   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Computed tomography guided percutaneous radiofrequency ablation (CT PRFA); Let 7; Lung cancer; Lung metastasis; miR 126; miR 34; miRNAs; Non small cell lung cancer (NSCLC)

Indexed keywords

MICRORNA 126; MICRORNA 155; MICRORNA 17 5P; MICRORNA 20B; MICRORNA 21; MICRORNA 34A; UNCLASSIFIED DRUG; MICRORNA; MICRORNA 17-5P; MICRORNA LET 7A;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; DOWN REGULATION; ELECTRODE; FEMALE; FOLLOW UP; HUMAN; LINEAR ENERGY TRANSFER; LIVER CELL CARCINOMA; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOFREQUENCY ABLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; UPREGULATION; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE EFFECTIVENESS; DRUG EFFICACY; DRUG MECHANISM; NON SMALL CELL LUNG CANCER; PRIMARY TUMOR; TREATMENT OUTCOME; CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; GENETICS; LIVER TUMOR; LUNG NEOPLASMS; PATHOLOGY; SECONDARY;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; ELECTRODES; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84899598507     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000358694     Document Type: Article

References (63)

1. Smith RA, Glynn TJ: Epidemiology of lung cancer. Radiol Clin N Am 2000;38:453-470. (Pubitemid 30350445)
2. Fry WA, Phillips JL, Menck HR: Ten-year survey of lung cancer treatment and survival in hospitals in the United States: A national cancer data base report. Cancer 1999; 86:1867-1876. (Pubitemid 29513058)
3. Spiro SG, Porter JC: Lung cancer-where are we todayAm J Respir Crit Care Med 2002;166:1166-1196.
4. Penna C, Nordlinger B: Colorectal metastasis (liver and lung). Surg Clin North Am 2002;82:1075-1090. (Pubitemid 35463085)
5. Penna C, Nordlinger B: Colorectal metastasis (liver and lung). Surg Clin North Am 2002;82:1075-1090. (Pubitemid 35463085)
6. Fernando HC, De Hoyos A, Landrenea u RJ, Gilbert S, Gooding WE, Buenaventura PO, Christie NA, Belani C, Luketich JD: Radiofrequency ablation for the treatment of non-small lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 2005; 129:639-44. (Pubitemid 40311325)
7. Herrera LJ, Fernando HC, Perry Y, Gooding WE, Buenaventura PO, Christie NA, Luketich JD: Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovas c Surg 2003;125:929-937. (Pubitemid 36457516)
8. Spira A, Ettinger DS: Multidisciplinary management of lung cancer. N Engl J Med 2004;350:379-392. (Pubitemid 38101633)
9. Marino P, Preatoni A, Cantoni A: Randomized trials of radiotherapy in stage IIIa and IIIb non-small cell lung cancer: A meta-analysis. Cancer 1995;176:593-601.
10. Siperstein A, Gotomirski A: History and technological aspects of radiofrequency thermoablation. Cancer J 2000;6:S293-301.
11. McGahan JP, Dodd III GD: Radiofrequency ablation of the liver: Current status. Am J Roentgenol 2001;176:3-16.
12. Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, Safran H: Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000;174:57-59. (Pubitemid 30030208)
13. Suh RD, Wallace AB, Sheehan RE, Heinze SB, Goldin JG: Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation-preliminary results. Radiology 2003;229:821-829. (Pubitemid 37467589)
14. Lee JM Jin GY Goldberg SN Lee YC Chung GH Han YM Lee SY Kim CS Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: Preliminary report Radiology 2004 230 125-134. (Pubitemid 37549793)
15. Gadaleta C, Mattioli V, Colucci G, Cramarossa A, Lorusso V, Canniello E, Timurian A, Ranieri G, Fiorentini G, De Lena M, Catino A: Radiofrequency ablation of 40 lung neoplasms: Preliminary re sults. AJR Am J Roentgenol 2004;183:361-368. (Pubitemid 38970326)
16. Nishida T, Inoue K, Kawata Y, Izumi N, Nishiyama N, Kinoshita H, Matsuoka T, Toyoshima M: Percutaneous radiofrequency ablation of lung neopla sms: A minimally invasive strategy for inoperable patients. J Am Coll Surg 2002;195:426-430. (Pubitemid 35006300)
17. Marasso A, Bernardi V, Gai R, Gallo E, Massaglia GM, Onoscuri M, Cardaci SB: Radiofrequency resec tion of bronchial tumors in combination with cryotherapy: Evaluation of a new technique. Thorax 1998;53:106-109. (Pubitemid 28212135)
18. Schoellnast H, Deodhar A, Hsu M, Moskowitz C, Nehmeh SA, Thornton RH, Sofocleous C T, Alago W Jr, Downey RJ, Azzoli CG, Rosenzweig KE, Solomon SB: Recurrent non-small cell lung cancer: Evaluation of CT-guided radiofrequency ablation as salvage therapy. Acta Radiol 2012;53:893-899.
19. Ding JH, Chua TC, Glenn D, Morris DL: Feasibility of ablation as an alternative to surgical metastasectomy in patients with unresectable sarcoma pulmonary metastases. Interact Cardiovasc Thorac Surg 2009;9:1051-1 053.
20. Hachisuka Y, Uomoto M, Fujisawa T, Mogami H: First reported case of lung metastasis from hepatocellular carcinoma successfully treated by ultrasound-guided radiofrequency ablation using ultrasonic contrast agent. Gan To Kagaku Ryoho 2009;36:2657-2659.
21. Hiraki T, Yamakado K, Ikeda O, Matsuoka T, Kaminou T, Yamagami T, Gobara H, Mimura H, Kawanaka K, Takeda K, Yamashita Y, Inoue Y, Ogawa T , Nishimura T, Kanazawa S: Percutaneous radiofrequency ablation for pulmonary metastases from hepatocellular carcinoma: Results of a multicenter study in Japan. J Vasc Interv Radiol 2011;22:741-748.
22. Hiraki T, Gobara H, Mimura H, Sano Y, Tsuda T, Iguchi T, Fujiwara H, Kishi R, Matsui Y, Kanazawa S: Does tumor type affect local control by radiofrequency ablation in the lungs Eur J Radiol 2010; 74:136-141.
23. Zhao B, Han H, Chen J, Zhang Z, Li S, Fang F, Zheng Q, Ma Y, Zhang J, Wu N, Yang Y: MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targe ting ITGB3 and MAP4K3. Cancer Lett 2014;342:43-51.
24. Capodanno A, Boldrini L, Proietti A, All G, Pelliccioni S, Niccoli C, D'Incecco A, Cappuzzo F, Chella A, Lucchi M, Mussi A, Fontanini G: Let-7g and miR-21 expression in non-small cell lung cancer: Correlation with clinicopathological and molecular features. Int J Oncol. 2013;43:765-774.
25. Jusufovic E, Rijavec M, Keser D, Kor osec P, Sodja E, Iljazovic E, Radojevic Z, Kosnik M: Let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in nonsmall-cell lung cancer. PLoS One 2012;7:e45577.
26. Wang YY, Ren T, Cai YY, He XY: MicroRNA let-7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K-Ras and HMGA2 gene expression. Cancer Biother Radiopharm 2 013;28:131-137.
27. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC: Unique micro RNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-198. (Pubitemid 43357945)
28. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, S u TJ, Chiang CC, Li HN, Hong QS, Su HY, Chen CC, Chen WJ, Liu CC, Chan WK, Chen WJ, Li KC, Chen JJ, Yang PC: MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008;13:48-57. (Pubitemid 350309743)
29. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T: Reduced expression of the let-7 microRN As in human lung cancers in association with shortened postoperative survival. Cancer Res 2004;64:3753-3756. (Pubitemid 38697282)
30. Yang J, Lan H, Huang X, Liu B, Tong Y: MicroRNA-126 inhibits tumor cell growth and its ex pression level correlates with poor survival in non-small cell lung cancer patients. PLoS One 2012;7:e42978.
31. Liu B, Peng XC, Zheng XL, Wang J, Qin YW: MiR-126 restoration down-regulate VEGF and inh ibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 2009;66:169-175.
32. Crawford M, Brawner E, Batte K, Yu L, Hunter MG, Otterson GA, Nuovo G, Marsh CB, Nana-Sinkam S P: MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun 2008;373:607-612.
33. Wang Z, Chen Z, Gao Y, Li N, Li B, Tan F, Tan X, Lu N, Sun Y, Sun J, Sun N, He J: DNA hypermethylation of microRNA-34b/c has prognostic value for stage I non-small cell lung cancer. Cancer Biol Ther 2011;11:490-496.
34. Wang LG, Ni Y, Su BH, Mu XR, Shen HC, Du JJ: MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met. Int J Oncol 2013;42:957-962.
35. Tanaka N, Toyooka S, Soh J, Kubo T, Yamamoto H, Maki Y, Muraoka T, Shien K, Furukawa M, Ueno T, Asano H, Tsukuda K, Aoe K, Miyoshi S: Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer. Lung Cancer 2012;76:32-38.
36. Gallardo E Navarro A Vinolas N Marrades RM Diaz T Gel B Quera A Bandres E Garcia-Foncillas J Ramirez J Monzo M miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer, Carcinogenesis 2009; 30; 1903-9190.
37. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG: MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Ca ncer Res 2009;69:5776-6783.
38. Saito M, Schetter AJ, Mollerup S, Kohno T, Skaug V, Bowman ED, Mathe EA, Takenoshita S, Yokota J, Haugen A, Harris CC: The association of microRNA expr ession with prognosis and progression in early stage, non small cell lung adenocarcinoma: A retrospective analysis of three cohorts. Clin Cancer Res 2011;17:1875-1882.
39. Liu ZL, Wang H, Liu J, Wang ZX: MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo-or radioresistance in non-small celllung cancer cells by targeting PTEN. Mol Cell Biochem 2013;372:35-45.
40. Yang M, Shen H, Qiu C, Ni Y, Wang L, Dong W, Liao Y, Du J: High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lungcancer. Eur J Cancer 2013; 49:604-615.
41. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T: A polycistronic microRNA cluster, miR-17-92, is overexpressed in h uman lung cancers and enhances cell proliferation. Cancer Res 2005;65:9628-9632. (Pubitemid 41541436)
42. Rossi S, Dore R, Cascina A, Vespro V, Garbagnati F, Rosa L, Ravetta V, Azzaretti A, Di Tolla P, Orland oni G, Pozzi E: Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours. Eur Respir J 2006;27:556-63. (Pubitemid 43372530)
43. Mountain CF, Dresler CM: Regional lymph node classification for lung cancer staging. Chest 1997;111:1718-1723. (Pubitemid 27260108)
44. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS, GOLD Scientific Committee: Global strategy for the diagnosis, management, and preventio n of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): Executive summary. Respir Care 2001;46:798-82 5. (Pubitemid 33759920)
45. Simon CJ, Dupuy DE, DiPetrillo TA, Safran HP, Grieco CA, Ng T, Mayo-Smith WW: Pulmonary radiofrequency ablation: Long-term safety and efficacy in 153 patients. Radiology 2007;243:268-275. (Pubitemid 46579719)
46. Thanos L, Mylona S, Pomoni M, Athanassiadi K, Theakos N, Zoganas L, Batakis N: Percutaneous radiofrequency thermal ablation of primary and metastatic lung tumors. Eur J Cardiothorac Surg 2006;30:797-800. (Pubitemid 44572776)
47. Ambrogi MC, Lucchi M, Dini P, Melfi F, Fontanini G, Faviana P, Fanucchi O, Mussi A: Percutaneous radiofrequency ablation of lung tumours: Results in the mid-term. Eur J Cardiothorac Surg 2006;30:177-183. (Pubitemid 43850341)
48. Thanos L, Mylona S, Pomoni M, Athanassiadi K, Theakos N, Zoganas L, Batakis N: Percutaneous radiofrequency thermal ablation of primary and metastatic lung tumors. Eur J Cardi othorac Surg 2006;30:797-800. (Pubitemid 44572776)
49. Hublet A, Wijtenburg E, Lismonde M, Thomas T, Majois F, De Lovinfosse S, Delaunoit T, Mitine C, Vermonden J, Nicaise G, Van Ruyssevelt P: Feasibility of percutaneous radiofrequency ablation for pulmonary malignancies in the hands of the surgeon. Acta Chir Belg 2010;110:267-271.
50. Schoellnast H, Larson SM, Nehmeh SA, Carrasquillo JA, Thornton RH, Solomon SB: Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance. Cardiovasc Intervent Radiol 2011;34 S uppl 2:S182-S185.
51. Okuma T, Matsuoka T, Yamamoto A, Oyama Y, Hamamoto S, Toyoshima M, Nakamura K, Miki Y: Determinants of local progression after computed tomography-guided percutaneous radiofrequ ency ablation for unresectable lung tumors: 9-year experience in a single institution. Cardiovasc Intervent Radiol 2010;33:787-793.
52. Tanabe T, Koizumi T, Tsushima K, Ito M, Kanda S, Kobayashi T, Yasuo M, Yamazaki Y, Kubo K, Honda T, Kondo R, Yoshida K: Comparative study of three different catheters for CT imaging-bronchoscopy-guided radiofrequency ablation as a potential and novel interventional therapy for lung cancer. Chest 2010;137:890-897.
53. Hiraki T, Gobara H, Iishi T, Sano Y, Iguchi T, Fujiwara H, Tajiri N, Sakurai J, Date H, Mimura H, Kanazawa S: Percutaneous radiofrequency ablation for pulmonary metastases from colorectal cancer: Midterm results in 27 patients. J Vasc Interv Radiol 2007;18:1264-1269. (Pubitemid 47446262)
54. Yamakado K, Hase S, Matsuoka T, Tanigawa N, Nakatsuka A, Takaki H, Takao M, Inoue Y, Kanazawa S, Inoue Y, Sawada S, Kusunoki M, Takeda K: Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: A multicenter study in Japan. J Vasc Interv Radiol 2007;18:393-398. (Pubitemid 46616705)
55. King J, Glenn D, Clark W, Zhao J, Steinke K, Clingan P, Morris DL: Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer. Br J Surg 2004;91:217-223. (Pubitemid 38233968)
56. Shu Yan Huo A, Lawson Morris D, King J, Glenn D: Use of percutaneous radiofrequency ablation in pulmonary metastases from renal cell carcinoma. Ann Surg Oncol 2009;16:31 69-3175.
57. Soga N Yamakado K Gohara H Takaki H Hiraki T Yamada T Arima K Takeda K Kanazawa S Sugimura Y Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal c ell carcinomaBJU Int2009 104 790-4.
58. Fernando HC, De Hoyos A, Landreneau RJ, Gilbert S, Gooding WE, Buenaventura PO, Christie NA, Belani C, Luketich JD: Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 2005;129:639-644. (Pubitemid 40311325)
59. Hiraki T, Gobara H, Iishi T, Sano Y, Iguchi T, Fujiwara H, Tajiri N, S akurai J, Date H, Mimura H, Kanazawa S: Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: Results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg 2007;134:1306-1312. (Pubitemid 47633617)
60. Ambrogi MC, Dini P, Melfi F, Mussi A: Radiofrequency ablation of inoperable non-small cell lung cancer. J Thorac Oncol 2007;2:S2-3.
61. Pennathur A, Luketich JD, Abbas G, Chen M, Fernando HC , Gooding WE, Schuchert MJ, Gilbert S, Christie NA, Landreneau RJ: Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. Thorac Cardiovasc Surg 2007;134:857-864 . (Pubitemid 47454625)
62. Hess A, Palussiere J, Goyers JF, Guth A, Auperin A, De Baere T: Pulmonary radiofrequency ablation in patients with a single lung: Feasibility, efficacy, and tolerance. Radiology 2011;258:635-6 42.
63. Zhu JC, Yan TD, Morris DL: A systematic review of radiofrequency ablation for lung tumors. Ann Surg Oncol 2008;15:765-1774.